196 related articles for article (PubMed ID: 17693875)
1. The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors.
Kim YH; Kim JS
Clin Orthop Relat Res; 2007 Dec; 465():33-9. PubMed ID: 17693875
[TBL] [Abstract][Full Text] [Related]
2. Mechanical thromboprophylaxis would suffice after total knee arthroplasties in Asian patients?
Kim YH; Anil V; Gaurav A; Park JW; Kim JS
Arch Orthop Trauma Surg; 2019 Feb; 139(2):167-171. PubMed ID: 30298379
[TBL] [Abstract][Full Text] [Related]
3. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
[TBL] [Abstract][Full Text] [Related]
4. Factors leading to decreased rates of deep vein thrombosis and pulmonary embolism after total knee arthroplasty.
Kim YH; Yoo JH; Kim JS
J Arthroplasty; 2007 Oct; 22(7):974-80. PubMed ID: 17920468
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study.
Ringwald J; Berger A; Adler W; Kraus C; Pitto RP
Clin Orthop Relat Res; 2009 Jun; 467(6):1507-15. PubMed ID: 18800213
[TBL] [Abstract][Full Text] [Related]
6. Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study.
Bedair H; Berli M; Gezer S; Jacobs JJ; Della Valle CJ
Clin Orthop Relat Res; 2011 Jan; 469(1):131-7. PubMed ID: 20824408
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the factor V Leiden paradox.
van Stralen KJ; Doggen CJ; Bezemer ID; Pomp ER; Lisman T; Rosendaal FR
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1872-7. PubMed ID: 18617648
[TBL] [Abstract][Full Text] [Related]
8. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
Martinelli I; Battaglioli T; Razzari C; Mannucci PM
J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
[TBL] [Abstract][Full Text] [Related]
9. Chemical Thromboprophylaxis Is Not Necessary to Reduce Risk of Thromboembolism With Tranexamic Acid After Total Hip Arthroplasty.
Kim YH; Park JW; Kim JS
J Arthroplasty; 2017 Feb; 32(2):641-644. PubMed ID: 27614816
[TBL] [Abstract][Full Text] [Related]
10. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors.
Westrich GH; Weksler BB; Glueck CJ; Blumenthal BF; Salvati EA
J Bone Joint Surg Am; 2002 Dec; 84(12):2161-7. PubMed ID: 12473703
[TBL] [Abstract][Full Text] [Related]
11. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.
Grifoni E; Marcucci R; Ciuti G; Cenci C; Poli D; Mannini L; Liotta AA; Miniati M; Abbate R; Prisco D
Semin Thromb Hemost; 2012 Mar; 38(2):230-4. PubMed ID: 22422337
[TBL] [Abstract][Full Text] [Related]
12. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study.
Kim YH; Oh SH; Kim JS
J Bone Joint Surg Br; 2003 Jul; 85(5):661-5. PubMed ID: 12892186
[TBL] [Abstract][Full Text] [Related]
13. Role of factor V Leiden or G20210A prothrombin mutation in patients with symptomatic pulmonary embolism and deep vein thrombosis: a meta-analysis of the literature.
Dentali F; Ageno W; Bozzato S; Malato A; Gianni M; Squizzato A; Prisco D
J Thromb Haemost; 2012 Apr; 10(4):732-7. PubMed ID: 22329698
[No Abstract] [Full Text] [Related]
14. Prevalence of deep vein thrombosis and pulmonary embolism treated with mechanical compression device after total hip arthroplasty.
Kim YH; Kulkarni SS; Park JW; Kim BS
J Arthroplasty; 2015 Apr; 30(4):675-80. PubMed ID: 25496929
[TBL] [Abstract][Full Text] [Related]
15. The influence of factor V Leiden and G20210A prothrombin mutation on the presence of residual vein obstruction after idiopathic deep-vein thrombosis of the lower limbs.
Cosmi B; Legnani C; Pengo V; Ghirarduzzi A; Testa S; Poli D; Prisco D; Tripodi A; Palareti G;
Thromb Haemost; 2013 Mar; 109(3):510-6. PubMed ID: 23306310
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosis.
Boyanovsky B; Russeva M; Ganev V; Penev M; Baleva M
Blood Coagul Fibrinolysis; 2001 Dec; 12(8):639-42. PubMed ID: 11734663
[TBL] [Abstract][Full Text] [Related]
17. A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran.
Karimi A; Abolhasani M; Hashemzadeh-Chaleshtori M; Pourgheysari B
Indian J Med Res; 2015 Jul; 142(1):46-52. PubMed ID: 26261166
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism.
de Moerloose P; Reber G; Perrier A; Perneger T; Bounameaux H
Br J Haematol; 2000 Jul; 110(1):125-9. PubMed ID: 10930988
[TBL] [Abstract][Full Text] [Related]
19. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
Rossi E; Za T; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2008 Jun; 99(6):1030-4. PubMed ID: 18521504
[TBL] [Abstract][Full Text] [Related]
20. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
